Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)

Shiga toxin (Stx)-producing Escherichia coli (STEC) infections are implicated in the development of the life-threatening Hemolytic Uremic Syndrome (HUS). Despite the magnitude of the social and economic problems caused by STEC infections, no licensed vaccine or effective therapy is presently availab...

Descripción completa

Detalles Bibliográficos
Autores principales: Mejías, Maria P., Hiriart, Yanina, Lauché, Constanza, Fernández-Brando, Romina J., Pardo, Romina, Bruballa, Andrea, Ramos, María V., Goldbaum, Fernando A., Palermo, Marina S., Zylberman, Vanesa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847011/
https://www.ncbi.nlm.nih.gov/pubmed/27118524
http://dx.doi.org/10.1038/srep24913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847011/
https://www.ncbi.nlm.nih.gov/pubmed/27118524
http://dx.doi.org/10.1038/srep24913

Ejemplares similares